-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $5.5

Benzinga·05/12/2026 16:31:19
Listen to the news
Morgan Stanley analyst Tejas Savant maintains Cytek Biosciences (NASDAQ:CTKB) with a Equal-Weight and lowers the price target from $6 to $5.5.